Abstract:Background Host Cell Proteins (HCPs) are impurities expressed in host cells during the biopharmaceutical production process, whichmay compromise product quality and potentially leading to immunogenic reactions or other adverse effects. Mass spectrometry (MS)-based strategy is more and more considered as a promising method for HCPs analysis, since it is capable of simultaneously quantifying thousands of proteins in a single test. However, considering the large excess biopharmaceutical product protein present in the system and the extremely low abundance of HCPs, sensitive MS methods are urgently needed in HCPs analysis. Results In this work, we introduced a novel approach that leveraged host cell lysate as a boosting channel to enhance the MS signal of the residue HCPs in biopharmaceutical products using isobaric TMT labeling, thereby elevating the low-abundant HCPs to detectable and quantifiable levels of current MS without using enrichment or depletion method to avoid disturbance of the original concentration of the HCPs. Our method surpassed previous benchmarks by identifying a significantly higher number (23844 unique peptides for 3475 proteins) compared to existing records (4541 unique peptides for 848 proteins) for HCPs analysis in RM8671 NIST monoclonal antibody (mAb), demonstrating unparalleled sensitivity and robustness. Furthermore, our workflow successfully identified 44 of 48 UPS1 proteins across a concentration range of 0.32–4.15 ppm in monoclonal antibodies (mAbs), proving its effectiveness for in-depth HCPs analysis in biopharmaceuticals. Significance Present even at sub-ppm levels, HCPs may compromise the stability and safety of product proteins and alter pharmacokinetics or neutralization of therapeutic effects. Our MS signal enhancing method presented an advancement in HCP analysis, combining improved sensitivity and increased scale of HCPs with a streamlined and robust workflow. This method allowed HCPs quantification at <1 ppm level without disturbance of the original HCPs concentration, which is still rare in the field.

Credibility ratings for desensitization and pseudotherapy among moderately and mildly snake-avoidant college students.

UV/Vis-based process analytical technology to improve monoclonal antibody and host cell protein separation

Host cell protein identification in monoclonal antibody high molecular weight species

Comprehensive host cell proteins profiling in biopharmaceuticals by a sensitivity enhanced mass spectrometry strategy using TMT-labeling and signal boosting

Optimized Sample Preparation and Data Processing of Data-Independent Acquisition Methods for the Robust Quantification of Trace-Level Host Cell Protein Impurities in Antibody Drug Products

Detection and quantitation of host cell proteins in monoclonal antibody drug products using automated sample preparation and data-independent acquisition LC-MS/MS

A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies

Identification and characterization of CHO host-cell proteins in monoclonal antibody bioprocessing

Characterization of the co‐elution of host cell proteins with monoclonal antibodies during protein A purification

SWATH-MS as a strategy for CHO host cell protein identification and quantification supporting the characterization of mAb purification platforms

Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development

[Anaphylactic shock with respiratory arrest after spontaneous rupture of echinococcal cyst in a 15-year-old patient].

Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification

Identification and classification of host cell proteins during biopharmaceutical process development

[Experiences in the treatment of patients in shock].

Select host cell proteins coelute with monoclonal antibodies in protein a chromatography

Host cell protein networks as a novel co‐elution mechanism during protein A chromatography

Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products

Host Cell Protein Analysis using Enrichment Beads Coupled with Limited Digestion

Risk Control of Host Cell Proteins in One Therapeutic Antibody Produced by Concentrated Fed‐batch (CFB) Mode

Carrier-Guided Proteome Analysis in a High Protein Background: An Improved Approach to Host Cell Protein Identification